Difference between revisions of "Ranimustine (Cymerin)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranimustine NCI Drug Dictionary]: A chloroethylnitrosourea derivative that i...") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Adult T-cell leukemia-lymphoma medications" to "Category:Adult T-cell leukemia/lymphoma medications") |
||
| Line 13: | Line 13: | ||
[[Category:Nitrosoureas]] | [[Category:Nitrosoureas]] | ||
| − | [[Category:Adult T-cell leukemia | + | [[Category:Adult T-cell leukemia/lymphoma medications]] |
[[Category:PMDA approved drugs]] | [[Category:PMDA approved drugs]] | ||
Revision as of 17:13, 1 March 2019
Mechanism of action
From the NCI Drug Dictionary: A chloroethylnitrosourea derivative that inhibits proliferation and growth of tumor cells by alkylation and cross-linkage of DNA strands of tumor cells.
Diseases for which it used
Also known as
- Generic name: MCNU, ranomustine
- Brand names: Cymer, Cymerin